CERS1 and obstructive sleep apnea syndrome: CERS1 was confirmed as a direct target, and its silencing reversed miR-1180-3p inhibition-mediated protection.<h4>Conclusion</h4>miR-1180-3p was a novel diagnostic biomarker for OSAHS.